Haber Karina, Hawkins Eleanor, Levie Mark, Chudnoff Scott
Department of Obstetrics and Gynecology, Danbury Hospital, Danbury, Connecticut; Department of Minimally Invasive Gynecological Surgery, Montefiore Medical Center, Bronx, New York.
Department of Obstetrics and Gynecology, Danbury Hospital, Danbury, Connecticut; Department of Minimally Invasive Gynecological Surgery, Montefiore Medical Center, Bronx, New York.
J Minim Invasive Gynecol. 2015 Jan;22(1):110-4. doi: 10.1016/j.jmig.2014.08.008. Epub 2014 Aug 14.
To investigate the number and type of adverse events associated with hysteroscopic morcellation of intrauterine disease.
Systematic review of Manufacturer and User Device Experience (MAUDE) database from 2005 to June 2014 (Canadian Task Force classification III).
SETTING N/A PATIENTS: Women undergoing hysteroscopic surgery for removal of intrauterine polyps or myomas with use of a reciprocating morcellator.
The MAUDE database was searched for the key words "Hysteroscope," "Hysteroscopic reciprocating morcellator," "Interlace," "MyoSure," "Smith & Nephew," and "TRUCLEAR," to identify reported incidences of device malfunction, injury, or death. A total of 119 adverse events were analyzed. Reports were reviewed individually and categorized by date of occurrence, type of morcellation device, type of complication, and a brief description. Each company was contacted to provide an estimate of the number of procedures performed or units sold to date.
From 2005 to June 2014, 119 adverse events were reported to the MAUDE database. On the basis of severity, adverse events were categorized as major or minor complications. Major events included intubation/admission to an intensive care unit (n = 14), bowel damage (n = 12), hysterectomy (n = 6), and death (n = 2). Minor events included uterine perforation requiring no other treatment (n = 29), device failure (n = 25), uncomplicated fluid overload (n = 19), postoperative bleeding controlled using noninvasive measures (n = 6), and pelvic infection (n = 4). These events were then categorized according to manufacturer. The number of adverse events reported to the MAUDE database was divided by the total units sold as a surrogate for the estimated number of procedures performed. Understanding the limitation of the numbers used as a numerator and denominator, we concluded that adverse events complicated hysteroscopic morcellation in <0.1% cases.
The suction-based, mechanical energy, rotating tubular cutting system was developed to overcome adverse events that occur during traditional resectoscopy. On the basis of acknowledged limited information from the MAUDE database, it seems that life-threatening complications such as fluid overload, uterine perforation, and bleeding do occur with hysteroscopic morcellation but less frequently than with traditional electrocautery.
调查与宫腔镜下子宫疾病粉碎术相关的不良事件的数量和类型。
对2005年至2014年6月的制造商和用户设备体验(MAUDE)数据库进行系统评价(加拿大工作组III级分类)。
地点 无 患者:接受宫腔镜手术以使用往复式粉碎器切除子宫息肉或肌瘤的女性。
在MAUDE数据库中搜索关键词“宫腔镜”、“宫腔镜往复式粉碎器”、“Interlace”、“MyoSure”、“史赛克”和“TRUCLEAR”,以确定报告的设备故障、损伤或死亡发生率。共分析了119例不良事件。对报告进行单独审查,并按发生日期、粉碎设备类型、并发症类型和简要描述进行分类。联系了每家公司,以提供截至目前已实施手术的数量或已售出设备数量的估计值。
2005年至2014年6月,MAUDE数据库共报告了119例不良事件。根据严重程度,不良事件分为主要并发症或次要并发症。主要事件包括插管/入住重症监护病房(n = 14)、肠道损伤(n = 12)、子宫切除术(n = 6)和死亡(n = 2)。次要事件包括无需其他治疗的子宫穿孔(n = 29)、设备故障(n = 25)、单纯性液体超负荷(n = 19)、使用非侵入性措施控制的术后出血(n = 6)和盆腔感染(n = 4)。然后根据制造商对这些事件进行分类。向MAUDE数据库报告的不良事件数量除以售出的设备总数,作为估计手术数量的替代指标。考虑到用作分子和分母的数字的局限性,我们得出结论,宫腔镜下粉碎术的不良事件发生率<0.1%。
基于抽吸的机械能旋转管状切割系统是为克服传统电切镜检查期间发生的不良事件而开发的。基于MAUDE数据库中公认的有限信息,宫腔镜下粉碎术似乎确实会发生诸如液体超负荷、子宫穿孔和出血等危及生命的并发症,但发生频率低于传统电灼术。